insights_auto
Why is ILMN up 5.14%?
Dive Deeperchevron_right
ILMN:NASDAQ
Illumina Inc
$278.17
arrow_upward
+5.14%(+13.60) 1D
$278.00
arrow_downward
-0.06% (-0.17)bedtimeAfter hours
Closed: Oct 9, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ILMN...
Open
$268.21
High
$278.59
Low
$265.25
Mkt. cap
42.00B
Avg. vol.
3.63M
Volume
1.90M
P/E ratio
51.70
52-wk high
$309.34
52-wk low
$88.00
EPS
$5.38
Beta
1.41
Shares outstanding
151.00M
No. of employees
9K
Open
$268.21
High
$278.59
Low
$265.25
Mkt. cap
42.00B
Avg. vol.
3.63M
Volume
1.90M
P/E ratio
51.70
52-wk high
$309.34
52-wk low
$88.00
EPS
$5.38
Beta
1.41
Shares outstanding
151.00M
No. of employees
9K
News stories
From web sources and news partners
Yahoo Finance
·
2 days ago
What is Illumina’s (ILMN) Economic Moat, and is it Widening or Narrowing?
Illumina
·
3 days ago
Illumina releases SpliceAI2 to help advance rare disease research
Profile
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.
Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies. Wikipedia
About Illumina Inc
CEOJacob Thaysen
Employees8.62K
Founded1998
HeadquartersSan Diego, California, United States
SectorHealth care
Websiteillumina.com